4 withdrawn. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 1 | 2 | Withdrawn 2 |
Follow Vision Disorders: new trials by email Literature Review of Vision Disorders trials Research Report on Vision Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Docosahexaenoic Acid (DHA) Supplementation in Amblyopia Docosahexaenoic Acid, Placebo Oral Tablet - Amblyopia | Phase 1 / Phase 2 | Withdrawn | Johns Hopkins University | 2024-01-01 | 2024-02-09 | |
| Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement Metformin - Bardet-Biedl Syndrome, Visual Impairment | Phase 2 | Withdrawn | University Hospital Tuebingen | 2018-04-01 | 2019-04-18 | |
| Caffeine in Amblyopia Study Caffeine - Amblyopia | Phase 1 / Phase 2 | Withdrawn | Johns Hopkins University | 2014-10-01 | 2017-03-07 | |
| Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself Visudyne, Lucentis, Dexamethasone - Age Related Macular Degeneration | Phase 2 | Withdrawn | Vitreous -Retina- Macula Consultants of New York | 2007-01-01 | 2017-08-23 |
Amblyopia (2) · Bardet-Biedl Syndrome (1) · Macular Degeneration (1)
Eye Diseases (4) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Sensation Disorders (4) · Signs and Symptoms (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Abnormalities, Multiple (1) · Ciliopathies (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1)
Caffeine (1) · Dexamethasone (1) · Docosahexaenoic Acids (1) · Metformin (1) · Ranibizumab (1) · Verteporfin (1)
Johns Hopkins University (2) · University Hospital Tuebingen (1) · Vitreous -Retina- Macula Consultants of New York (1)
United States (2)
Courtney Kraus, MD (1) · Heiko Billing, PD Dr. med. (1) · Michael X Repka, MD, MBA (1)